Hess' shares continue to meander


It's a difficult call, but I'm Reiterating my Buy rating for Hess Corp. (NYSE: HES), first recommended on April 22, 2009 at a price of $50.41.

Hess' shares have underperformed over the past half-year, but I'm sticking with the play, for now, pending results over the next two quarters.

Hess is vulnerable if U.S. gasoline demand does not pick-up in the second half of Q2, but with 'green shoots' in the U.S. economy surfacing, the risk/return is favorable for investors who can tolerate moderate risk. The First Call FY2009/FY2010 EPS estimates for HES are $1.25 to $3.45.

Stock Analysis: Hess is a moderate-risk stock. If you've already purchased the company's shares, hold them. If not, consider buying a 25% position in HES now. Under any circumstance, don't buy more than 25% of your HES position before October 2009. Sell/Stop Loss if you were to buy shares in this company: $32.

- -

Disclosure: Lazzaro has no positions in stocks, but does own shares in two Pimco Bond Funds: PHDAX and PYMAX.
Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 13, 2012: 08:19 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329139180972 ms.